EMA Withdrawn: Pantoloc Control (pantoprazole) — Takeda GmbH

View source ↗

Summary

Pantoloc Control (pantoprazole) has been withdrawn from the European market by Takeda GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoloc Control (pantoprazole)

Snippet

Status: Withdrawn. Therapeutic area: Gastroesophageal Reflux. MAH: Takeda GmbH. Decision date: 14/01/2021